Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by Law.com, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!

X

Demand for patent work increases due to new first-to-file system

Even as overall demand for legal work decreased, patent work demand stayed strong

It looks like IP is the place to be.

During the first quarter of 2013, demand for intellectual property patent work from law firms rose by 5.1 percent, while demand for almost all other major practice areas decreased, according to the Peer Monitor Index, which gathers data from about 145 of the top 250 law firms in the U.S.

The increased demand for IP work makes sense when you consider that just last month the U.S. Patent and Trademark Office (PTO) switched from a first-to-invent to a first-to-file patent filing system. According to Thomson Reuters, many entities swarmed the PTO with applications, trying to take advantage of the old rules before they expired. On March 15, the day before the new rules went into effect, the PTO received 13,888 applications.

Outside the patent world, things didn’t look so rosy for law firms in 2013’s first quarter. Demand for legal services overall dropped by 3.4 percent. Labor and employment, typically a strong practice, fell by 9 percent, and general litigation fell by 3.7 percent.

 

Read more about patents on InsideCounsel:

Cheat Sheet: A 5-minute guide to the EU’s new unitary patent system

IP: India, generics and the impact of Novartis’ failed Gleevec claims

FDA considering petition to protect biologic medications’ patents

Federal Circuit invalidates Bayer’s Yaz patent

Join the Conversation

Advertisement. Closing in 15 seconds.